EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anticancer Mechanisms of Ginsenoside Compound K: A Review

Yu-Po Lee iD, Hui-Ting Chan, Tzu-Hsuan Li, Lichieh Julie Chu iD, Sheau-Long Lee, Yu-Quan Chang, Robert Yl Wang iD

Diseases · 05.05.2025 · 13 (5) · 143

DOI: 10.3390/diseases13050143 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 05.05.2025. Verfasst von Yu-Po Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Industry Master and Ph.D. Program, Chang Gung University, Taoyuan 333323, Taiwan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, Chang Gung Memorial Hospital Research Fund, Chang Gung University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer, also known as malignant tumors, is formed due to abnormal mutations and the proliferation of human cells. Cancer cells not only demonstrate accelerated proliferation but also show robust invasive and metastatic potential, disseminating from a primary affected region of the body to multiple areas and potentially culminating in organ dysfunction or failure, thereby jeopardizing the individual’s life. The rapid growth of the biopharmaceutical market has given rise to numerous novel medicines, thereby precipitating a paradigm shift in contemporary drug development methodologies. This modification is focused on identifying methodologies that can effectively target cancerous cells while minimizing damage to normal cells. There is an increasing societal movement that supports the utilization of natural ingredients derived from plants. In recent years, traditional herbal medicine has experienced a surge in popularity within the global cancer market. In comparison with the use of more toxic chemotherapy methods, there has been an increasing focus on advanced therapies that exhibit reduced side effects. Ginsenoside compound K (CK) is derived from the natural components in ginseng through biotransformation. The utilization of CK in cancer research is a practice engaged in by numerous scientists. The underlying rationale is that CK exhibits a multitude of effects within the realm of cancer research, including but not limited to the mitigation of inflammation, the suppression of cancerous cell proliferation, and the safeguarding of cardiovascular, hepatic, and renal functions. This review methodically identifies and organizes CK-related journals according to the following key points of cancer treatment: the effects on cancer cells themselves, angiogenesis inhibition, modulation of immune response to identify cancer cells, and inflammation regulation. The intricate interplay between ginsenoside CK and cells is elucidated through a graphical representation. The present review focuses on the results of CK in in vitro tests. It is our hope that the present article will aid future studies on the results of CK in vivo tests, clarify the correlation between cellular mechanisms in vivo and in vitro tests, and assist in the development of drugs.

Schlagwörter

Stichwörter der Autor:innen

angiogenesiscancerchronic inflammationginsenoside compound Kstromal cell-derived factor 1

Autor:innen und Institutionen

  • Biotechnology Industry Master and Ph.D. Program, Chang Gung University, Taoyuan 333323, Taiwan.
  • Wellhead Biological Technology Corp., Taoyuan 325019, Taiwan.
  • Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan.
  • Department of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan.
  • Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Linkou 333423, Taiwan.

ORCID-Profile: Yu-Po Lee, Lichieh Julie Chu, Robert Yl Wang

Förderung

  • National Science and Technology Council, Taiwan
  • Chang Gung Memorial Hospital Research Fund
  • Chang Gung University

Zitieren

APA

Lee, Y. P., Chan, H. T., Li, T. H., Chu, L. J., Lee, S. L., Chang, Y. Q., & Wang, R. Y. (2025). Anticancer Mechanisms of Ginsenoside Compound K: A Review. Diseases, 13(5), 143. https://doi.org/10.3390/diseases13050143

Vancouver

Lee YP, Chan HT, Li TH, Chu LJ, Lee SL, Chang YQ, et al. Anticancer Mechanisms of Ginsenoside Compound K: A Review. Diseases. 2025;13(5):143. doi:10.3390/diseases13050143

BibTeX
@article{Lee2025,
  author = {Lee, Yu-Po and Chan, Hui-Ting and Li, Tzu-Hsuan and Chu, Lichieh Julie and Lee, Sheau-Long and Chang, Yu-Quan and Wang, Robert Yl},
  title = {Anticancer Mechanisms of Ginsenoside Compound K: A Review},
  journal = {Diseases},
  year = {2025},
  volume = {13},
  number = {5},
  pages = {143},
  doi = {10.3390/diseases13050143}
}
Kostenlos starten →